European Guideline ( EuroGuiDerm ) on atopic eczema: Living update
University Hospital Augsburg · Ludwig-Maximilians-Universität München · +39 more institutions
Abstract
The evidence- and consensus-based living guideline on atopic eczema was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. The original EuroGuiDerm Guideline on atopic eczema was published in June 2022. Since then, the part of the guideline dealing with systemic therapy has been updated twice. This paper summarizes the results of the second update. Twenty-eight experts (including clinicians and patient representatives) from 12 European countries participated. The updated guideline provides guidance on which patients should be treated with systemic therapies, as well as recommendations and detailed information on each systemic drug. The systemic treatment options…
Citation impact
- FWCI
- 65.34
- Percentile
- 100%
- References
- 118
Authors
32- AWAndreas WollenbergCorresponding
University Hospital Augsburg, Ludwig-Maximilians-Universität München, University of Lübeck
- MKMaria Kinberger
Humboldt-Universität zu Berlin, Freie Universität Berlin, Charité - Universitätsmedizin Berlin
- BAB.W.M. Arents
European Federation of Allergy and Airways Diseases Patients Associations
- NAN. Aszodi
Ludwig-Maximilians-Universität München
- SBS. Barbarot
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement, PhysioPathologie des Adaptations Nutritionnelles, Nantes Université
Topics & keywords
- Medicine
- Guideline
- Ciclosporin
- Dupilumab
- Azathioprine
- Intensive care medicine
- Atopic dermatitis
- Omalizumab